# Gloucester Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gloucester-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.gloucesterpharma.com
- Total disclosed funding: $77M
- Latest round: Series D (Aug 14, 2009)
- Investors on record: 6

## About

Founded in 2002, Gloucester Pharmaceuticals, Inc., a biopharmaceutical company, acquires clinical-stage oncology drug candidates for regulatory approval and commercialization.

## Funding rounds

- Series D, Aug 14, 2009, $20M — Prospect Venture Partners, RHO, Apple Tree Partners, ProQuest Investments, Novo Holdings A/S
- Series C, May 2, 2008, $42M — Prospect Venture Partners, CIBC Capital Partners, ProQuest Investments
- Series B, Oct 14, 2004, $15M — Prospect Venture Partners, RHO, CIBC Capital Partners, Apple Tree Partners, ProQuest Investments

## Investors

- Prospect Venture Partners (https://capitalatlas.ai/funds/prospect-venture-partners) — Series B, Series C, Series D
- RHO (https://capitalatlas.ai/funds/rho) — Series B, Series D
- CIBC Capital Partners — Series B, Series C
- Apple Tree Partners (https://capitalatlas.ai/funds/apple-tree-partners) — Series B, Series D
- ProQuest Investments (https://capitalatlas.ai/funds/proquest-investments) — Series B, Series C, Series D
- Novo Holdings A/S — Series D